IBIO News $IBIO INVESTOR ALERT: Faruqi & Faruq
Post# of 150
Posted On: 11/05/2014 5:58:39 AM
IBIO News $IBIO
INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in iBio, Inc. (IBIO) to Contact the Firm
Marketwired - Sat Nov 01, 8:30AM CDT
Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in iBio, Inc. ("iBio" or the "Company"
(NYSE: IBIO) of the December 23, 2014 deadline to seek the role of lead plaintiff in a federal securities class action lawsuit filed against iBio and the Company's CEO.
IBIO: 1.19 (+0.11)
Morgan & Morgan Announces That a Class Action Lawsuit Has Been Filed Against iBio, Inc. -- IBIO
GlobeNewswire - Fri Oct 31, 2:15PM CDT
Morgan & Morgan announces that a class action has been commenced in the United States District Court for the District of Delaware on behalf of investors who purchased iBio, Inc. ("iBio" or the "Company" (NYSE:IBIO) securities between October 13, 2014 and October 23, 2014.
IBIO: 1.19 (+0.11)
Robbins Arroyo LLP: iBio, Inc. (IBIO) Misled Shareholders According to a Recently Filed Class Action
GlobeNewswire - Wed Oct 29, 5:27PM CDT
Shareholder rights law firm Robbins Arroyo LLP announces that an investor of iBio, Inc. (NYSE:IBIO) has filed a federal securities fraud class action complaint in the U.S. District Court for the District of Delaware. The complaint alleges that the company and certain of its officers and directors violated the Securities Exchange Act of 1934 between October 13, 2014 and October 23, 2014. iBio is a biotechnology company that focuses on the commercialization of proprietary plant-based protein expression technologies in the United States and internationally.
IBIO: 1.19 (+0.11)
SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in iBio, Inc. to Contact Brower Piven Before the Lead Plaintiff Deadline in Class Action Lawsuit -- IBIO
GlobeNewswire - Wed Oct 29, 12:57PM CDT
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of Delaware on behalf of purchasers of iBio, Inc. ("iBio" or the "Company" (NYSE:IBIO) common stock during the period between October 13, 2014 and October 23, 2014, inclusive (the "Class Period" . Investors who wish to become proactively involved in the litigation have until December 23, 2014 to seek appointment as lead plaintiff.
IBIO: 1.19 (+0.11)
SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP Notifies Investors of Class Action Against iBio, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of December 23, 2014 -- IBIO
GlobeNewswire - Wed Oct 29, 10:45AM CDT
Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the District of Delaware on behalf of investors who purchased iBio, Inc. ("iBio" or the "Company" (NYSE MKT:IBIO) securities between October 13, 2014 and October 23, 2014.
IBIO: 1.19 (+0.11)
Market Maker Surveillance Report. SIRI, KEG, IBIO, GRNH, EGXKP, FB, Highest Net Sell Volume and Negative Price Friction For Tuesday, October 28th 2014
M2 - Wed Oct 29, 4:44AM CDT
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Tuesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Tuesday there were 4520 companies with "abnormal" market making, 3969 companies with positive Friction Factors and 1393 companies with negative Friction Factors. Here is a list of the top companies with the highest net sell volume on Tuesday and lowest negative price Friction (bearish). This means that there was more selling than buying in the stocks and their stock prices dropped faster with less Friction. Sirius XM Radio Inc (NASDAQ:SIRI), Key Energy Services Inc (NYSE:KEG), Ibio Inc (NYSE:IBIO), Greengro Technologies Inc (OTC:GRNH), (OTC:EGXKP), Facebook Inc (NASDAQ:FB). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .
FB: 75.76 (+1.88), KEG: 2.48 (-0.36), IBIO: 1.19 (+0.11), SIRI: 3.48 (unch)
Harwood Feffer LLP Announces Investigation of iBio, Inc.
PR Newswire - Tue Oct 28, 7:00PM CDT
Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of iBio, Inc. ("iBio" or the "Company" (NYSE: IBIO), concerning whether the board has breached its fiduciary duties to shareholders.
IBIO: 1.19 (+0.11)
INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In iBio, Inc. (IBIO) To Contact The Firm
PR Newswire - Tue Oct 28, 4:05PM CDT
Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in iBio, Inc. ("iBio" or the "Company" (NYSE: IBIO) of the December 23, 2014 deadline to seek the role of lead plaintiff in a federal securities class action lawsuit filed against iBio and the Company's CEO.
IBIO: 1.19 (+0.11)
Hagens Berman Notifies Investors That a Class Action With a Lead Plaintiff Deadline of December 23, 2014 Has Been Filed Against iBio, Inc. (NYSE MKT: IBIO)
GlobeNewswire - Tue Oct 28, 7:33AM CDT
Hagens Berman Sobol Shapiro LLP, a national investor-rights law firm, alerts investors that a class action lawsuit has been filed against iBio, Inc. (NYSE MKT:IBIO) ("iBio" or "the Company). The suit is pending in U.S. District Court for the District of Delaware and investors have until December 23, 2014 to move for lead plaintiff.
IBIO: 1.19 (+0.11)
Gainey McKenna & Egleston Announces a Class Action Lawsuit Has Been Filed Against iBio, Inc. -- IBIO
GlobeNewswire - Mon Oct 27, 6:30PM CDT
Gainey McKenna & Egleston announces that a class action lawsuit has been filed in the United States District Court for the District of Delaware, on behalf of all persons who purchased or otherwise acquired iBio, Inc. ("IBIO" or the "Company" (NYSE:IBIO) securities during the period between October 13, 2014 and October 23, 2014, inclusive, inclusive (the "Class Period" . This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the "Exchange Act" .
IBIO: 1.19 (+0.11)
EQUITY ALERT: The Rosen Law Firm Files Securities Class Action Against iBio, Inc. -- IBIO
GlobeNewswire - Fri Oct 24, 9:30PM CDT
The Rosen Law Firm announces that it has filed a class action lawsuit against iBio, Inc. (NYSE MKT:IBIO) on behalf of all purchasers of the Company's common stock between October 13, 2014 and October 23, 2014, inclusive. The lawsuit seeks to recover damages for iBio shareholders under the federal securities laws.
IBIO: 1.19 (+0.11)
The Rosen Law Firm Announces Investigation of Securities Fraud Claims Against iBio, Inc. - IBIO
Business Wire - Thu Oct 23, 4:21PM CDT
The Rosen Law Firm, P.A. announces that it is investigating potential securities fraud claims against iBio, Inc. (NYSE: IBIO).
IBIO: 1.19 (+0.11)
IBio (IBIO) Is Today's Dead Cat Bounce Stock
at The Street - Wed Oct 22, 8:49AM CDT
Trade-Ideas LLC identified iBio (IBIO) as a "dead cat bounce" (down big yesterday but up big today) candidate
IBIO: 1.19 (+0.11)
iBio Expands Exclusive Product Collaboration With Novici Biotech
Marketwired - Wed Oct 22, 7:32AM CDT
iBio, Inc. (NYSE MKT: IBIO), a leading provider of plant-based biotechnology for developing and manufacturing biological products, and Novici Biotech LLC (Novici) have agreed to broaden their commercial collaboration, currently focused on antibodies and certain vaccine products, to include iBio's proprietary IBIO-CFB03 product for idiopathic pulmonary fibrosis, systemic sclerosis and other fibrotic diseases. This expanded program will combine the strength of the iBioLaunch(TM) platform with Novici's patented GRAMMR(R) technology for rapid evolution of gene sequences to significantly increase expression yield of target proteins.
IBIO: 1.19 (+0.11)
Ebola Stocks May Be Overpriced as Fundamentals Outweigh Fear
at The Street - Tue Oct 21, 5:10AM CDT
Ebola stocks have soared in recent weeks but a closer look at fundamentals may serve as a reality check for investors playing the story.
RAI: 64.37 (+0.36), IBIO: 1.19 (+0.11)
Why iBio (IBIO) Stock Is Plummeting Today
at The Street - Mon Oct 20, 9:45AM CDT
Shares of pharmaceutical company iBio (IBIO) plunged in morning trading Monday after some positive announcements about the Ebola outbreak.
IBIO: 1.19 (+0.11)
How to Trade the Market's Most-Active Stocks
at The Street - Fri Oct 17, 2:18PM CDT
Here's how to trade some of the most active stocks on the market today.
GE: 25.70 (unch), HAL: 51.18 (-2.70), IBIO: 1.19 (+0.11)
Why iBio (IBIO) Stock Continues to Soar Today
at The Street - Fri Oct 17, 9:33AM CDT
Shares of iBio (IBIO) surged again in morning trading Friday as the Ebola outbreak continues.
IBIO: 1.19 (+0.11)
Why iBio (IBIO) Stock Is Soaring Today
at The Street - Thu Oct 16, 8:58AM CDT
Shares of iBio (IBIO) soared in morning trading Thursday after the company announced it has offered to aid the U.S. government in fighting Ebola with its proprietary antibody production technology.
IBIO: 1.19 (+0.11)
iBio Responds to Inquiries About its Role in Emergency Response to Ebola Virus Disease Outbreak
Marketwired - Thu Oct 16, 7:31AM CDT
iBio, Inc. (NYSE MKT: IBIO) today confirmed, in response to shareholder and media inquiries: (i) the applicability of its issued U.S. iBioLaunch(TM) platform patents and related proprietary technology to further development and production of antibodies that target the Ebola virus, and (ii) that iBio has an ongoing relationship with Caliber Biotherapeutics LLC reflected by a License and Collaboration Agreement dated February 14, 2013 pursuant to which iBio and Caliber have been collaborating on commercial opportunities for recombinant antibodies and antibody-related proteins based on the speed, efficiency, and cost advantages of producing pharmaceutical proteins in plants instead of with bioreactor-based manufacturing methods.
IBIO: 1.19 (+0.11)
INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in iBio, Inc. (IBIO) to Contact the Firm
Marketwired - Sat Nov 01, 8:30AM CDT
Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in iBio, Inc. ("iBio" or the "Company"
(NYSE: IBIO) of the December 23, 2014 deadline to seek the role of lead plaintiff in a federal securities class action lawsuit filed against iBio and the Company's CEO. IBIO: 1.19 (+0.11)
Morgan & Morgan Announces That a Class Action Lawsuit Has Been Filed Against iBio, Inc. -- IBIO
GlobeNewswire - Fri Oct 31, 2:15PM CDT
Morgan & Morgan announces that a class action has been commenced in the United States District Court for the District of Delaware on behalf of investors who purchased iBio, Inc. ("iBio" or the "Company"
(NYSE:IBIO) securities between October 13, 2014 and October 23, 2014. IBIO: 1.19 (+0.11)
Robbins Arroyo LLP: iBio, Inc. (IBIO) Misled Shareholders According to a Recently Filed Class Action
GlobeNewswire - Wed Oct 29, 5:27PM CDT
Shareholder rights law firm Robbins Arroyo LLP announces that an investor of iBio, Inc. (NYSE:IBIO) has filed a federal securities fraud class action complaint in the U.S. District Court for the District of Delaware. The complaint alleges that the company and certain of its officers and directors violated the Securities Exchange Act of 1934 between October 13, 2014 and October 23, 2014. iBio is a biotechnology company that focuses on the commercialization of proprietary plant-based protein expression technologies in the United States and internationally.
IBIO: 1.19 (+0.11)
SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in iBio, Inc. to Contact Brower Piven Before the Lead Plaintiff Deadline in Class Action Lawsuit -- IBIO
GlobeNewswire - Wed Oct 29, 12:57PM CDT
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of Delaware on behalf of purchasers of iBio, Inc. ("iBio" or the "Company"
(NYSE:IBIO) common stock during the period between October 13, 2014 and October 23, 2014, inclusive (the "Class Period" . Investors who wish to become proactively involved in the litigation have until December 23, 2014 to seek appointment as lead plaintiff. IBIO: 1.19 (+0.11)
SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP Notifies Investors of Class Action Against iBio, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of December 23, 2014 -- IBIO
GlobeNewswire - Wed Oct 29, 10:45AM CDT
Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the District of Delaware on behalf of investors who purchased iBio, Inc. ("iBio" or the "Company"
(NYSE MKT:IBIO) securities between October 13, 2014 and October 23, 2014. IBIO: 1.19 (+0.11)
Market Maker Surveillance Report. SIRI, KEG, IBIO, GRNH, EGXKP, FB, Highest Net Sell Volume and Negative Price Friction For Tuesday, October 28th 2014
M2 - Wed Oct 29, 4:44AM CDT
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Tuesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Tuesday there were 4520 companies with "abnormal" market making, 3969 companies with positive Friction Factors and 1393 companies with negative Friction Factors. Here is a list of the top companies with the highest net sell volume on Tuesday and lowest negative price Friction (bearish). This means that there was more selling than buying in the stocks and their stock prices dropped faster with less Friction. Sirius XM Radio Inc (NASDAQ:SIRI), Key Energy Services Inc (NYSE:KEG), Ibio Inc (NYSE:IBIO), Greengro Technologies Inc (OTC:GRNH), (OTC:EGXKP), Facebook Inc (NASDAQ:FB). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .
FB: 75.76 (+1.88), KEG: 2.48 (-0.36), IBIO: 1.19 (+0.11), SIRI: 3.48 (unch)
Harwood Feffer LLP Announces Investigation of iBio, Inc.
PR Newswire - Tue Oct 28, 7:00PM CDT
Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of iBio, Inc. ("iBio" or the "Company"
(NYSE: IBIO), concerning whether the board has breached its fiduciary duties to shareholders. IBIO: 1.19 (+0.11)
INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In iBio, Inc. (IBIO) To Contact The Firm
PR Newswire - Tue Oct 28, 4:05PM CDT
Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in iBio, Inc. ("iBio" or the "Company"
(NYSE: IBIO) of the December 23, 2014 deadline to seek the role of lead plaintiff in a federal securities class action lawsuit filed against iBio and the Company's CEO. IBIO: 1.19 (+0.11)
Hagens Berman Notifies Investors That a Class Action With a Lead Plaintiff Deadline of December 23, 2014 Has Been Filed Against iBio, Inc. (NYSE MKT: IBIO)
GlobeNewswire - Tue Oct 28, 7:33AM CDT
Hagens Berman Sobol Shapiro LLP, a national investor-rights law firm, alerts investors that a class action lawsuit has been filed against iBio, Inc. (NYSE MKT:IBIO) ("iBio" or "the Company). The suit is pending in U.S. District Court for the District of Delaware and investors have until December 23, 2014 to move for lead plaintiff.
IBIO: 1.19 (+0.11)
Gainey McKenna & Egleston Announces a Class Action Lawsuit Has Been Filed Against iBio, Inc. -- IBIO
GlobeNewswire - Mon Oct 27, 6:30PM CDT
Gainey McKenna & Egleston announces that a class action lawsuit has been filed in the United States District Court for the District of Delaware, on behalf of all persons who purchased or otherwise acquired iBio, Inc. ("IBIO" or the "Company"
(NYSE:IBIO) securities during the period between October 13, 2014 and October 23, 2014, inclusive, inclusive (the "Class Period" . This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the "Exchange Act" . IBIO: 1.19 (+0.11)
EQUITY ALERT: The Rosen Law Firm Files Securities Class Action Against iBio, Inc. -- IBIO
GlobeNewswire - Fri Oct 24, 9:30PM CDT
The Rosen Law Firm announces that it has filed a class action lawsuit against iBio, Inc. (NYSE MKT:IBIO) on behalf of all purchasers of the Company's common stock between October 13, 2014 and October 23, 2014, inclusive. The lawsuit seeks to recover damages for iBio shareholders under the federal securities laws.
IBIO: 1.19 (+0.11)
The Rosen Law Firm Announces Investigation of Securities Fraud Claims Against iBio, Inc. - IBIO
Business Wire - Thu Oct 23, 4:21PM CDT
The Rosen Law Firm, P.A. announces that it is investigating potential securities fraud claims against iBio, Inc. (NYSE: IBIO).
IBIO: 1.19 (+0.11)
IBio (IBIO) Is Today's Dead Cat Bounce Stock
at The Street - Wed Oct 22, 8:49AM CDT
Trade-Ideas LLC identified iBio (IBIO) as a "dead cat bounce" (down big yesterday but up big today) candidate
IBIO: 1.19 (+0.11)
iBio Expands Exclusive Product Collaboration With Novici Biotech
Marketwired - Wed Oct 22, 7:32AM CDT
iBio, Inc. (NYSE MKT: IBIO), a leading provider of plant-based biotechnology for developing and manufacturing biological products, and Novici Biotech LLC (Novici) have agreed to broaden their commercial collaboration, currently focused on antibodies and certain vaccine products, to include iBio's proprietary IBIO-CFB03 product for idiopathic pulmonary fibrosis, systemic sclerosis and other fibrotic diseases. This expanded program will combine the strength of the iBioLaunch(TM) platform with Novici's patented GRAMMR(R) technology for rapid evolution of gene sequences to significantly increase expression yield of target proteins.
IBIO: 1.19 (+0.11)
Ebola Stocks May Be Overpriced as Fundamentals Outweigh Fear
at The Street - Tue Oct 21, 5:10AM CDT
Ebola stocks have soared in recent weeks but a closer look at fundamentals may serve as a reality check for investors playing the story.
RAI: 64.37 (+0.36), IBIO: 1.19 (+0.11)
Why iBio (IBIO) Stock Is Plummeting Today
at The Street - Mon Oct 20, 9:45AM CDT
Shares of pharmaceutical company iBio (IBIO) plunged in morning trading Monday after some positive announcements about the Ebola outbreak.
IBIO: 1.19 (+0.11)
How to Trade the Market's Most-Active Stocks
at The Street - Fri Oct 17, 2:18PM CDT
Here's how to trade some of the most active stocks on the market today.
GE: 25.70 (unch), HAL: 51.18 (-2.70), IBIO: 1.19 (+0.11)
Why iBio (IBIO) Stock Continues to Soar Today
at The Street - Fri Oct 17, 9:33AM CDT
Shares of iBio (IBIO) surged again in morning trading Friday as the Ebola outbreak continues.
IBIO: 1.19 (+0.11)
Why iBio (IBIO) Stock Is Soaring Today
at The Street - Thu Oct 16, 8:58AM CDT
Shares of iBio (IBIO) soared in morning trading Thursday after the company announced it has offered to aid the U.S. government in fighting Ebola with its proprietary antibody production technology.
IBIO: 1.19 (+0.11)
iBio Responds to Inquiries About its Role in Emergency Response to Ebola Virus Disease Outbreak
Marketwired - Thu Oct 16, 7:31AM CDT
iBio, Inc. (NYSE MKT: IBIO) today confirmed, in response to shareholder and media inquiries: (i) the applicability of its issued U.S. iBioLaunch(TM) platform patents and related proprietary technology to further development and production of antibodies that target the Ebola virus, and (ii) that iBio has an ongoing relationship with Caliber Biotherapeutics LLC reflected by a License and Collaboration Agreement dated February 14, 2013 pursuant to which iBio and Caliber have been collaborating on commercial opportunities for recombinant antibodies and antibody-related proteins based on the speed, efficiency, and cost advantages of producing pharmaceutical proteins in plants instead of with bioreactor-based manufacturing methods.
IBIO: 1.19 (+0.11)
(0)
(0)Ibio (IBIO) Stock Research Links
Scroll down for more posts ▼